Atorvastatin protects against cyclophosphamide-induced thyroid injury in rats via modulation of JNK/ ERK/ p38 MAPK signaling pathway
Walaa Yehia Abdelzaher, Seham A. Abdel-Gaber, Michael Atef Fawzy, Abdel Hamid Sayed Abo Bakr Ali, Mina Ezzat Attya, Ayman Geddawy
Topics & Concepts
MAPK/ERK pathwayPharmacologyAtorvastatinp38 mitogen-activated protein kinasesInternal medicineThyroidEndocrinologyMedicineMalondialdehydeKinaseOxidative stressChemistryBiochemistryCancer, Lipids, and MetabolismChemotherapy-induced cardiotoxicity and mitigationThyroid Cancer Diagnosis and Treatment